Kearney, Caitlin A.
Brinks, Anna L.
Needle, Carli D.
Adhikari, Samrachana
Marks, Douglas K.
Shapiro, Jerry
Tattersall, Ian W.
Lo Sicco, Kristen I.
Lacouture, Mario E.
Article History
Received: 3 June 2025
Accepted: 25 September 2025
First Online: 21 November 2025
Declarations
:
: Dr. Lacouture is an investigator for Hoth Therapeutics, a consultant for Hoth Therapeutics and Marengo Therapeutics, and the president of the Oncodermatology Society. Dr. Lo Sicco is an investigator for Pfizer, a consultant for Pfizer, Veradermics, Priovant, and Acquis, and a board member of the Scarring Alopecia Foundation and American Hair Research Society. Dr. Shapiro is an investigator for Pfizer and a consultant for Pfizer, Lilly, Replicel Life Science, Regen Lab, Thirty Madison, DS Laboratories, and Almirall. Drs. Adhikari, Marks, and Tattersall, and authors Kearney, Brinks, and Needle have no relevant conflicts of interest to disclose.
: Not applicable.
: Not applicable.
: Not applicable.